欧洲首例肾移植受者糖尿病与非糖尿病死亡趋势:ERA登记研究
糖尿病为肾衰竭病因者占15.5%,其死亡率近非糖尿病者两倍(45.5 vs 24.9/1000人年),主要归因于心血管和感染死亡。无论有无糖尿病,全因和心血管标化死亡率随时间未改善,心血管死亡差距未缩小;COVID-19期间两组死亡率均上升。
要点
- 糖尿病为肾衰竭病因的肾移植受者死亡率近非糖尿病者两倍。
- 超额死亡主要来自心血管死亡和感染相关死亡。
- 标化全因和心血管死亡率未随时间改善,与一般人群趋势相反。
核心结论
- 与一般人群相反,肾移植受者年龄和性别标化全因及心血管死亡率未随时间改善。
- 有无糖尿病肾移植受者间心血管死亡差距未随时间缩小。
研究设计与样本
- 共纳入134,231例成人,其中20,753例(15.5%)糖尿病为肾衰竭病因。
- 计算年龄和性别标化死亡率,采用Joinpoint回归分析时间趋势。
主要发现
- 糖尿病为肾衰竭病因者死亡率45.5/1000人年,非糖尿病者24.9/1000人年。
- 糖尿病受者超额死亡主要来自心血管死亡和感染相关死亡。
- COVID-19大流行前,两组全因和死因别死亡率趋势稳定。
- COVID-19期间两组死亡率均上升,主要由感染相关死亡增加驱动。
临床怎么用
- 对糖尿病为肾衰竭病因的肾移植受者应加强心血管和感染风险管理。
- 肾移植受者死亡率未见改善,需持续关注长期存活并优化管理。
局限性
- 随访最多5年,可能不足以观察长期趋势。
- 观察性设计无法推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although all-cause and cause-specific mortality trends are well studied in the general population, these trends were less explored in kidney transplant recipients with and without diabetes. Our aim was to examine time trends in (cause-specific) mortality in adult first kidney transplant recipients with and without diabetes as the cause of kidney failure in European countries. METHODS: We included adult patients who received a first kidney transplant between 2005 and 2022 from twelve European countries contributing data to the European Renal Association (ERA) Registry. We followed patients for a maximum of 5 years. We calculated age- and sex-standardised mortality rates, and the absolute and relative mortality differences between those with and without diabetes. Time trends were analyzed using Joinpoint regression. RESULTS: In total, 134,231 adults received a kidney transplant between 2005 and 2022, and 20,753 (15.5%) of them had diabetes as the cause of kidney failure. Mortality rates for kidney transplant recipients with diabetes were almost twice as high as for recipients without diabetes (45.5 deaths per 1000 person-years (py) and 24.9 per 1000 py, respectively). The higher mortality of recipients with diabetes was mainly due to excess cardiovascular mortality and infection-related mortality. Trends in all-cause and cause-specific mortality remained stable over time up to the COVID-19 pandemic for recipients with and without diabetes. During the COVID-19 pandemic, both groups experienced an increase in mortality rates, mainly driven by an increase in infection-related mortality. CONCLUSIONS: Contrary to trends observed in the general population, age- and sex-standardised all-cause and cardiovascular mortality rates among kidney transplant recipients, irrespective of diabetes status, did not improve over time. In addition, in contrast to the general population, the cardiovascular mortality gap in kidney transplant recipients with and without diabetes did not narrow over time.
引用
- Oliveras L, Boenink R, Kramer A, et al. Trends in mortality in adult first kidney transplant recipients with and without diabetes as cause of kidney failure: an ERA Registry study. Nephrol Dial Transplant. 2026. PMID: 42616007. doi:10.1093/ndt/gfag188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。